Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma

Archives of Surgery

Volumn 137, Issue 6, 2002, Pages 653-658

  Lopez Jr , Richard R ^a   Pan, Shi Hui ^a   Hoffman, Allen L ^a   Ramirez, Carlos ^a   Rojter, Sergio E ^a   Ramos, Hector ^a   McMonigle, Michael ^a   Lois, Juan ^a  

^a ST VINCENT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DOXORUBICIN; ETHIODIZED OIL; MITOMYCIN; POLYVINYL ALCOHOL SPONGE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036277431     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.137.6.653     Document Type: Article

References (27)

1. The epidemiology and prevention of hepatocellular carcinoma
2. Natural history of hepatocellular carcinoma and prognosis in relation to treatment
3. Diagnosis and nonsurgical treatment of hepatocellular carcinoma
4. Imaging of hepatocellular carcinoma: A practical approach
5. Hepatocellular carcinoma
6. Pathology of hepatocellular carcinoma
7. Histological typing of tumours of the liver
8. Histologic prognostic indicators in hepatocellular carcinoma
9. Experience with 225 hepatic resections for hepatocellular carcinoma over a 4-year period
10. Surgical management of large hepatocellular carcinomas: Criteria for curative hepatectomy
11. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma: A prospective randomized trial
12. Intra-arterial and intravenous use of 4′ epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma: A randomized comparison
13. Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma: A phase II study
14. Ablative techniques for hepatocellular carcinoma
15. Transcatheter oily chemoembolization for hepatocellular carcinoma
16. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma
17. Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization
18. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
19. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
20. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
21. Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies
22. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
23. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States
24. The effectiveness of serum α-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma
25. The general rules for the clinical and pathological study of primary liver cancer
26. Hepatic artery embolization in 120 patients with unresectable hepatoma